Sage Journals: Discover world-class research

Open access

Case report

First published 2022

Unique SLC12A2-ROS1 fusion is associated with marked response to crizotinib in lung adenocarcinoma

Maurício Fernando Silva Almeida Ribeiro, Luiza Lara Gadotti, Karina Perez Sacardo [...]

Sage Open Medical Case Reports

Open access

Research article

First published 2020-12

Driver gene alterations in lung adenocarcinoma: Demographic features of 2544 Chinese cases

Mingming Hu, Tongmei Zhang, Yuan Yang [...]

The International Journal of Biological Markers

Open access

Research article

First published 2015

Synergistic Effects of Crizotinib and Temozolomide in Experimental FIG-ROS1 Fusion-Positive Glioblastoma

Arabinda Das, Ron Ron Cheng, Megan L.T. Hilbert [...]

Cancer Growth and Metastasis

Open access

Case report

First published 2020-3

The coexistence of ROS1-rearranged lung adenocarcinoma and pulmonary tuberculosis in a critical ill young patient

Hui Zhu, Xiao-Qin Wang, Hai-Yan Lu

Journal of International Medical Research

Retricted access

Research article

First published 2018-9

Immunoexpression of BAP1,ROS1,and ALK in Spitzoid Melanocytic Tumors

Leonardo Cardili, Cristiano Ribeiro Viana, Andressa Germano [...]

International Journal of Surgical Pathology

Free access

Review article

First published 2016-4

Management of advanced non-small cell lung cancers with known mutations or rearrangements: latest evidence and treatment approaches

Meghan Shea, Daniel B. Costa, Deepa Rangachari

Therapeutic Advances in Respiratory Disease

Open access

Case report

First published 2025-2

Lorlatinib experience in a patient with ALK + non-small cell lung cancer on hemodialysis: A case report

Ali Fuat Gürbüz, Melek Karakurt Eryılmaz, Oğuzhan Yıldız [...]

Journal of Oncology Pharmacy Practice

Search results

Unique SLC12A2-ROS1 fusion is associated with marked response to crizotinib in lung adenocarcinoma

Driver gene alterations in lung adenocarcinoma: Demographic features of 2544 Chinese cases

Synergistic Effects of Crizotinib and Temozolomide in Experimental FIG-ROS1 Fusion-Positive Glioblastoma

The coexistence of ROS1-rearranged lung adenocarcinoma and pulmonary tuberculosis in a critical ill young patient

Immunoexpression of BAP1,ROS1,and ALK in Spitzoid Melanocytic Tumors

Management of advanced non-small cell lung cancers with known mutations or rearrangements: latest evidence and treatment approaches

Lorlatinib experience in a patient with ALK + non-small cell lung cancer on hemodialysis: A case report